NCT00275652View on ClinicalTrials.gov

A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.

PHASE3CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Hepatitis BCirrhosis
Interventions
DRUG

LdT (Telbivudine) and lamivudine

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Mayo Clinic

OTHER

NCT00275652 - A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis. | Biotech Hunter | Biotech Hunter